Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
Details for Australian Patent Application No. 2004217510 (hide)
International Classifications
Event Publications
6 October 2005 PCT application entered the National Phase
PCT publication WO2004/078924 Priority application(s): WO2004/078924
14 June 2007 Assignment before Grant
RheoGene, Inc. The application has been assigned to Intrexon Corporation
9 December 2010 Application Accepted
Published as AU-B-2004217510
7 April 2011 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 09 Mar 2011. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2005
28 July 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 09 Mar 2011 2005
4 August 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser